Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: A prospective observational study

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Matera, Giovanni ^a   Puccio, Rossana ^a   Giancotti, Aida ^a   Quirino, Angela ^a   Pulicari, Maria Concetta ^a   Zicca, Emilia ^a   Caroleo, Santo ^a   Renzulli, Attilio ^a   Liberto, Maria Carla ^a   Focà, Alfredo ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; BIOLOGICAL MARKER; IL10 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN;

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; AGED; BACTEREMIA; BLOOD; MIDDLE AGED;

AGED; BACTEREMIA; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84875849208     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12596     Document Type: Article

References (31)

1. Wang EH, Devereaux RS, Yealy DM, Safford MM, Howard G. National variation in United States sepsis mortality: a descriptive study. Int J Health Geogr 2010, 9:9. 10.1186/1476-072X-9-9, 2831852, 20156361.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35:1244-1250. 10.1097/01.CCM.0000261890.41311.E9, 17414736.
3. Remick DG. Pathophysiology of sepsis. Am J Pathol 2007, 170:1435-1444. 10.2353/ajpath.2007.060872, 1854939, 17456750.
4. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005, 365:63-78. 10.1016/S0140-6736(04)17667-8, 15639681.
5. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008, 14:64-78. 2078557, 18026569.
6. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891. 10.1038/nature01326, 12490963.
7. Saito K, Wagatsuma T, Toyama H, Ejima Y, Hoshi K, Shibusawa M, Kato M, Kurosawa S. Sepsis is Characterized by the increases in percentages of circulating CD4+ CD25+ regulatory T cells and plasma levels of soluble CD25. Tohoku J Exp Med 2008, 216:61-68. 10.1620/tjem.216.61, 18719339.
8. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations. Crit Care Med 2008, 36:941-952. 10.1097/CCM.0B013E318165BABB, 18431284.
9. Maruna P, Nedẽlni{hook above}kovǎ K, Gu{double acute}rlich R. Physiology and Genetics of procalcitonin. Physiol Res 2000, 49:S57-S61.
10. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341:515-518. 10.1016/0140-6736(93)90277-N, 8094770.
11. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis, and organ dysfunction. Crit Care 2004, 8:R234-R242. 10.1186/cc2877, 522844, 15312223.
12. Povoa P. C-reactive protein a valuable marker of sepsis. Intensive Care Med 2002, 28:235-243. 10.1007/s00134-002-1209-6, 11904651.
13. Spapen HD, Hachimi-Idrissi S, Corne L, Huyghens LP. Diagnostic markers of sepsis in the emergency department. Acta Clin Belg 2006, 61:138-142.
14. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010, 14:R15. 10.1186/cc8872, 2875530, 20144219.
15. De Bard AL, Vautrin C, Pariset C, Bienvenu J, Monneret G. High serum procalcitonin levels do not predict bacteremia in adult patiens with acute fever. Clin Infect Dis 2003, 36:825-826. 10.1086/368095, 12627373.
16. Flohé SB, Agrawal H, Flohé S, Rani M, Bangen JM, Schade FU. Diversity of Interferon γ and Granulocyte-Macrophage Colony-Stimulating Factor in Restoring Immune Dysfunction of Dendritic Cells and Macrophages During Polymicrobial Sepsis. Mol Med 2008, 14:247-256. 2249752, 18297128.
17. Kasten KR, Tschöp J, Goetzman HS, England LG, Dattilo JR, Cave CM, Seitz AP, Hildeman DA, Caldwell CC. T-cell activation differentially mediates the host response to sepsis. Shock 2010, 4:377-383.
18. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
19. Rangel-Frausto MS, Pittet D, Hwang T, Woolson RF, Wenzel RP. The dynamic of disease progression in sepsis: Markov modeling describing the natural history and the likely impact of anti-septic agents. Clin Infect Dis 1998, 27:185-190. 10.1086/514630, 9675475.
20. Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2005, 38:404-415. 10.1016/j.jbi.2005.02.008, 16198999.
21. Osuchowski MF, Welch K, Yang H, Siddiqui J, Remick DG. Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol 2007, 179:623-630.
22. Marshall JC. Sepsis: rethinking the approach to clinical research. J Leukoc Biol 2008, 83:471-482.
23. Tang BMP, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217. 10.1016/S1473-3099(07)70052-X, 17317602.
24. Harbarth S, Holeckova K, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J,. Geneva Sepsis Network Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Car Med 2001, 164:396-402. Geneva Sepsis Network.
25. Abe R, Hirasawa H, Oda S, Sadahiro T, Nakamura M, Watanabe E, Nakada TA, Hatano M, Tokuhisa T. Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J Surg Res 2008, 147:1-8. 10.1016/j.jss.2007.07.009, 17720196.
26. Dorresteijn MJ, Pickkers P, Netea MG, Van der Hoeven JG. IFN-gamma is not induced through increased plasma concentrations of interleukin-12/interleukin-18 during human endotoxemia. Eur Cytokine Netw 2005, 16:191-193.
27. O'Dwyer MJ, Mankan AK, Stordeur P, O' Connell B, Duggan E, White M, Kelleher DP, McManus R, Ryan T. The occurrence of severe sepsis and septic shock are related to distinct patterns of cytokine gene expression. Shock 2006, 26:544-550. 10.1097/01.shk.0000235091.38174.8d, 17117127.
28. Murphy TJ, Paterson HM, Mannick JA, Lederer JA. Injury, sepsis, and the regulation of Toll-like receptor responses. J Leukoc Biol 2004, 75:400-407.
29. Ward NS, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med 2008, 29:617-625. 10.1016/j.ccm.2008.06.010, 2786900, 18954697.
30. Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, Tattevin P, Thomas R, Fauchet R, Drénou B. Early Circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002, 18:487-494. 10.1097/00024382-200212000-00001, 12462554.
31. Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532. 10.1038/nri2343, 2665249, 18566595.